Effects of melatonin administration on chemical pregnancy rates of polycystic ovary syndrome patients undergoing intrauterine insemination: A randomized clinical trial

International Journal of Fertility and Sterility

Volumn 13, Issue 3, 2019, Pages 225-229

  Mokhtari, Fataneh ^a   Asbagh, Firouzeh Akbari ^a   Azmoodeh, Ozra ^a   Bakhtiyari, Mahmood ^b,c   Almasi Hashiani, Amir ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

Author keywords

Mature Follicle; Melatonin; Polycystic Ovary Syndrome; Pregnancy Rate

Indexed keywords

CHORIONIC GONADOTROPIN; MELATONIN; PLACEBO; ZUCLOMIFENE CITRATE;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOMETRIAL THICKNESS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; HYSTEROSALPINGOGRAPHY; IN VITRO FERTILIZATION; INTRAUTERINE INSEMINATION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUATION; OOCYTE MATURATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; OXIDATIVE STRESS; PREGNANCY RATE; PRESCRIPTION; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; ULTRASOUND;

EID: 85069708964     PISSN: 2008076X     EISSN: 20080778     Source Type: Journal    
DOI: 10.22074/ijfs.2019.5717     Document Type: Article

References (32)

1. Dewailly D, Hieronimus S, Mirakian P, Hugues JN. Polycystic ovary syndrome (PCOS). Ann Endocrinol (Paris). 2010; 71(1): 8-13.
2. Irez T, Ocal P, Guralp O, Cetin M, Aydogan B, Sahmay S. Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI out-comes. Arch Gynecol Obstet. 2011; 284(5): 1295-1301.
3. Dyer S, Chambers GM, de Mouzon J, Nygren KG, Zegers-Hoch-schild F, Mansour R, et al. International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology 2008, 2009 and 2010. Hum Reprod. 2016; 31(7): 1588-1609.
4. Levran D, Farhi J, Nahum H, Royburt M, Glezerman M, Weissman A. Prospective evaluation of blastocyst stage transfer vs. zygote in-trafallopian tube transfer in patients with repeated implantation fail-ure. Fertil Steril. 2002; 77(5): 971-977.
5. Ruiz-Alonso M, Blesa D, Díaz-Gimeno P, Gómez E, Fernández-Sánchez M, Carranza F, et al. The endometrial receptivity array for diagnosis and personalized embryo transfer as a treatment for patients with repeated implantation failure. Fertil Steril. 2013; 100(3): 818-824.
6. Martins WP, Rocha IA, Ferriani RA, Nastri CO. Assisted hatching of human embryos: a systematic review and meta-analysis of randomized controlled trials. Hum Reprod Update. 2011; 17(4): 438-453.
7. Shen MS, Wang CW, Chen CH, Tzeng CR. New horizon on successful management for a woman with repeated implantation failure due to unresponsive thin endometrium: use of extended estrogen supplementation. J Obstet Gynaecol Res. 2013; 39(5): 1092-1094.
8. Gunby J, Bissonnette F, Librach C, Cowan L; IVF Directors Group of the Canadian Fertility and Andrology Society. Assisted reproductive technologies (ART) in Canada: 2007 results from the Canadian ART Register. Fertil Steril. 2011; 95(2): 542-547. e1-10.
9. Nastri CO, Lensen SF, Gibreel A, Raine-Fenning N, Ferriani RA, Bh-attacharya S, et al. Endometrial injury in women undergoing assisted reproductive techniques. Cochrane Database Syst Rev. 2015; (3): CD009517.
10. Teixeira DM, Barbosa MA, Ferriani RA, Navarro PA, Raine-Fenning N, Nastri CO, et al. Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction. Cochrane Database Syst Rev. 2013; (7): CD010167.
11. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005; 3(1): 28.
12. Carlomagno G, Nordio M, Chiu TT, Unfer V. Contribution of myo-inositol and melatonin to human reproduction. Eur J Obstet Gynecol Reprod Biol. 2011; 159(2): 267-272.
13. Batıoğlu AS1, Sahin U, Gürlek B, Oztürk N, Unsal E. The efficacy of melatonin administration on oocyte quality. Gynecol Endocrinol. 2012; 28(2): 91-93.
14. Manda K, Ueno M, Anzai K. AFMK, a melatonin metabolite, attenu-ates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res. 2007; 42(4): 386-393.
15. Unfer V, Raffone E, Rizzo P, Buffo S. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oo-cyte quality: a prospective, longitudinal, cohort study. Gynecol Endo-crinol. 2011; 27(11): 857-861.
16. Papaleo E, Unfer V, Baillargeon J-P, Fusi F, Occhi F, De Santis L. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertil Steril. 2009; 91(5): 1750-1754.
17. Rizzo P, Raffone E, Benedetto V. Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial. Eur Rev Med Pharmacol Sci. 2010; 14(6): 555-561.
18. Aitken RJ, De Iuliis GN, Drevet JR. Role of oxidative stress in the etiology of male infertility and the potential therapeutic value of an-tioxidants. In: Henkel R, Samanta L, Agarwal A. Oxidants, antioxi-dants and impact of the oxidative status in male reproduction. USA: Academic Press; 2019; 91-100.
19. Fernando S, Rombauts L. Melatonin: shedding light on infertility?-A review of the recent literature. J Ovarian Res. 2014; 7: 98.
20. Fernando S, Osianlis T, Vollenhoven B, Wallace E, Rombauts L. A pilot double-blind randomised placebo-controlled dose-response trial assessing the effects of melatonin on infertility treatment (MIART): study protocol. BMJ Open. 2014; 4(8): e005986.
21. Zhang L, Zhang Z, Wang F, Tian X, Ji P, Liu G. Effects of melatonin administration on embryo implantation and offspring growth in mice under different schedules of photoperiodic exposure. Reprod Biol Endocrinol. 2017; 15(1): 78.
22. Succu S, Pasciu V, Manca ME, Chelucci S, Torres-Rovira L, Leoni GG, et al. Dose-dependent effect of melatonin on postwarming development of vitrified ovine embryos. Theriogenology. 2014; 81(8): 1058-1066.
23. Eryilmaz OG, Devran A, Sarikaya E, Aksakal FN, Mollamahmutoğlu L, Cicek N. Melatonin improves the oocyte and the embryo in IVF patients with sleep disturbances, but does not improve the sleeping problems. J Assist Reprod Genet. 2011; 28(9): 815-820.
24. Batioglu AS, Sahin U, Gurlek B, Ozturk N, Unsal E. The efficacy of melatonin administration on oocyte quality. Gynecol Endocrinol. 2012; 28(2): 91-93.
25. Nishihara T, Hashimoto S, Ito K, Nakaoka Y, Matsumoto K, Hosoi Y, et al. Oral melatonin supplementation improves oocyte and embryo quality in women undergoing in vitro fertilization-embryo transfer. Gynecol Endocrinol. 2014; 30(5): 359-362.
26. Unfer V, Raffone E, Rizzo P, Buffo S. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oo-cyte quality: a prospective, longitudinal, cohort study. Gynecol Endo-crinol. 2011; 27(11): 857-861.
27. Jahromi BN, Sadeghi S, Alipour S, Parsanezhad ME, Alamdarloo SM. Effect of melatonin on the outcome of assisted reproductive technique cycles in women with diminished ovarian reserve: A dou-ble-blinded randomized clinical trial. Iran J Med Sci. 2017; 42(1): 73-78.
28. Tamura H, Takasaki A, Miwa I, Taniguchi K, Maekawa R, Asada H, et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res. 2008; 44(3): 280-287.
29. Nikmard F, Hosseini E, Bakhtiyari M, Ashrafi M, Amidi F, Aflatoonian R. Effects of melatonin on oocyte maturation in PCOS mouse model. Anim Sci J. 2017; 88(4): 586-592.
30. Dair EL, Simoes RS, Simoes MJ, Romeu LR, Oliveira-Filho RM, Haidar MA, et al. Effects of melatonin on the endometrial morphology and embryo implantation in rats. Fertil Steril. 2008; 89(5 Suppl): 1299-1305.
31. Seko LM, Moroni RM, Leitao VM, Teixeira DM, Nastri CO, Martins WP. Melatonin supplementation during controlled ovarian stimula-tion for women undergoing assisted reproductive technology: systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2014; 101(1): 154-161. e4.
32. Yang HL, Zhou WJ, Gu CJ, Meng YH, Shao J, Li DJ, et al. Pleiotropic roles of melatonin in endometriosis, recurrent spontaneous abortion, and polycystic ovary syndrome. Am J Reprod Immunol. 2018; 80(1): e12839.